Injectable Drug Delivery Devices Market Size | Forecast 2031
Injectable Drug Delivery Devices Market Size | Forecast 2031
Segments - Injectable Drug Delivery Devices Market by Device Types (Conventional Drug Delivery Devices and Self-injectable Drug Delivery Devices, Advanced Drug Delivery Devices [Prefilled Syringes, Injectable Pens, Auto Injectors, Needle-free Injectors, and Others], Therapeutic Applications (Cardiovascular Diseases, Diabetes, Oncology, Autoimmune Disorders, Hepatitis, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023–2031
Upcoming
| Report ID :HC-1183
| 4.5 Rating
| 76 Reviews
| 190 Pages
| Format :
Report Description
Injectable Drug Delivery Devices Market Outlook 2031
The global injectable drug delivery devices market size was USD 96.14 Billion in 2022 and is expected to reach USD 256.08 Billion by 2031 expand at a healthy CAGR 11.5% during the forecast period, 2023-2031. The growth of the market is attributed to growing prevalence of chronic diseases such as cardiovascular diseases, obesity, and diabetes. Moreover, rising use of disposable syringes due to rising burden of chronic diseases is driving the market growth.
A major number of drugs and therapies that address these chronic ailments are available. However, the use of syringes in the management of any chronic ailment is inevitable. Syringes can either be a part of sample collection during diagnosis or treatment regimen such as osteoarthritis.
Injectable Drug Delivery Devices Market Drivers, Restraints, Trends, and Opportunities
- Rising technological advancements and improving patient compliance are expected to propel the market growth.
- Beneficial reimbursement policies and rising number of biologics in the pharmaceutical market are anticipated to spur the growth of the market.
- The advantages of self-injectable injections and increasing awareness about self-administration are speculated to proliferate the market growth.
- The COVID-19 outbreak has encouraged pharmaceutical companies to develop vaccines, which in turn, has created lucrative opportunities during the forecast period.
Scope of the Injectable Drug Delivery Devices Market Report
The report on the injectable drug delivery devices market includes an assessment of the market, trends, segments and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Injectable Drug Delivery Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Types (Conventional Drug Delivery Devices and Advanced Drug Delivery Devices (Prefilled Syringes, Injectable Pens, Auto Injectors, Needle-free Injectors, Other Device Types), Therapeutic Applications (Cardiovascular Diseases, Diabetes, Oncology, Autoimmune Disorders, Hepatitis, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Baxter International Inc., Becton, Dickinson and Company, Gerresheimer AG, Teva Pharmaceutical Industries Ltd, and Eli Lilly and Company |
Injectable Drug Delivery Devices Market Segment Insights
Self-injectable drug delivery devices segment to account a large market share
Based on types, the market is divided into conventional drug delivery devices, self-injectable drug delivery devices, and advanced drug delivery devices. The advanced drug delivery devices segment is further segmented into prefilled syringes, injectable pens, auto injectors, needle-free injectors, and others. The self-Injectable drug delivery devices segment is projected to account for a large market share during the forecast period.
Rising number of diabetes patient is expected to propel the segment growth. Self-injectable devices are convenient to use and are inexpensive in nature. Rising innovation in self-injectable devices is expected to further boost the segment growth.
Diabetes segment to exhibit a high CAGR
On the basis of therapeutic applications, the market is classified as cardiovascular diseases, diabetes, oncology, autoimmune disorders, hepatitis, and others. The diabetes segment is projected to expand at a high CAGR during the forecast period. Rising prevalence of diabetes is driving the market segment growth. Diabetes is one of the most common diseases around the world. Many people use insulin injections to cope with the disease. Hence, the demand for injectable drug delivery devices is growing at a healthy rate in the market.
North America to account a considerable market share
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to account for a considerable market share during the forecast period. The segment growth is attributed to the increasing geriatric population and rising incidence of chronic diseases in the countries such as the US and Canada. Increasing healthcare expenditure, rising focus on health, and growing government funding are expected to foster the regional market growth.
Segments
The global injectable drug delivery devices market has been segmented on the basis of:
Type
- Conventional Drug Delivery Devices
- Self-injectable Drug Delivery Devices
- Advanced Drug Delivery Devices
- Prefilled Syringes
- Injectable Pens
- Auto Injectors
- Needle-free Injectors
- Others
Therapeutic Applications
- Cardiovascular Diseases
- Diabetes
- Oncology
- Autoimmune Disorders
- Hepatitis
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key players
- Baxter International Inc.
- Becton, Dickinson and Company
- Gerresheimer AG
- Teva Pharmaceutical Industries Ltd
- Eli Lilly and Company
Competitive Landscape
Some of the major players in the market are Baxter International Inc., Becton, Dickinson and Company, Gerresheimer AG, Teva Pharmaceutical Industries Ltd, and Eli Lilly and Company.
The companies operating in the market are focusing on product innovation, expansion, and exploring new markets. Moreover, they’re partnering with local manufacturers to expand their market share.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Injectable Drug Delivery Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Injectable Drug Delivery Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Injectable Drug Delivery Devices Market - Supply Chain
4.5. Global Injectable Drug Delivery Devices Market Forecast
4.5.1. Injectable Drug Delivery Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Injectable Drug Delivery Devices Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Injectable Drug Delivery Devices Market Absolute $ Opportunity
5. Global Injectable Drug Delivery Devices Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Injectable Drug Delivery Devices Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
6. North America Injectable Drug Delivery Devices Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
7. Latin America Injectable Drug Delivery Devices Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
8. Europe Injectable Drug Delivery Devices Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
9. Asia Pacific Injectable Drug Delivery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
10. Middle East & Africa Injectable Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Injectable Drug Delivery Devices Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Injectable Drug Delivery Devices Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Injectable Drug Delivery Devices Market: Market Share Analysis
11.2. Injectable Drug Delivery Devices Distributors and Customers
11.3. Injectable Drug Delivery Devices Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Baxter International Inc.
11.4.2. Becton, Dickinson and Company
11.4.3. Gerresheimer AG
11.4.4. Teva Pharmaceutical Industries Ltd
11.4.5. Eli Lilly and Company
Methodology
Related Reports
Some other reports from this category!
Our Clients
